Psychedelic research center launched at New York’s Mount Sinai
Named the Center for Psychedelic Psychotherapy and Trauma Research the institution is first focusing on MDMA-assisted psychotherapy for PTSD.
Public health & disease
From disease eradication efforts to advances in vaccination and maternal health, this archive tracks real progress in public health. Stories here focus on what’s working — policies, interventions, and research that are improving and extending lives around the world.
Phase 1 human trial for universal flu vaccine reports promising results
The Phase 1 trial, led by researchers from the Icahn School of Medicine at Mount Sinai, found this experimental vaccine to be both safe and effective at generating a long-term immune response in a small number of healthy adults.
U.N. reclassifies cannabis as a less dangerous drug
Cannabis is no longer classified as a Schedule IV drug as per WHO’s recommendation. The declassification opens up the door for more research into its medicinal and therapeutic uses.
First of-its-kind study suggests psilocybin can help treat migraines
A first-of-its-kind exploratory study, led by researchers from Yale School of Medicine, has found a single dose of the psychedelic psilocybin can reduce migraine frequency by 50 percent for a least two weeks.
Elephantiasis cases cut by 150 million worldwide since 2000
Over the last 20 years, however, the number of people infected has dropped by 74%, from 199 million to 51.4 million, and last year three countries—Malawi, Kiribati, and Yemen—eliminated it altogether.
New HIV diagnoses in British gay and bisexual men hits 20-year-low
A new report shows that there were 1,700 new HIV diagnoses in gay and bisexual men in 2000. In 2019, new HIV diagnoses stood at 1,500. HIV transmission has fallen by 80% between 2011 when there was an estimated peak of 2,700 cases and 2019 when there was an estimated 540.
WHO rolls out plan to rid world of cervical cancer, saving millions of lives
The strategy involves vaccinating 90% of girls by the age of 15, screening 70% of women by the age of 35 and again by the age of 45, and treating 90% of women identified with cervical disease.
Promising flu vaccine derived from tobacco plant passes clinical trials
The recent development, promises to be a huge boost to the annual fight against the seasonal flu, as plants can be engineered to produce viral proteins and cultivated at scale.
Childhood Hepatitis B cases drop 80% worldwide in last three decades
Due to a highly effective global vaccine program, the proportion of children under five who are chronically infected with Hepatitis B has plummeted significantly—to just under 1%. This is down from around 5% in the pre-vaccine era (the period between the 1980s and the early 2000s), according to new estimates from the World Health Organization.
Tuberculosis deaths have fallen by 14% in five years, saving 60 million in the last two decades
In the World Health Organization’s annual global tuberculosis report, the UN agency responsible for international public health forecasts hundreds of thousands of people recovering from, or avoiding the disease of TB altogether. Since 2000, TB treatment has averted the deaths of 60 million people, the disease itself being treatable with the right medicine.